ConductScience.org, home

Paper3315098

The biological consequences of altered MHC expression on tumours.

Festenstein H. Br Med Bull, 1987. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. The biological consequences of altered MHC expression on tumours. Papers, record 3315098. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3315098

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The biological consequences of altered MHC expression on tumours.
PubMed
Journal
Br Med Bull
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.31
iCite
Revised in PubMed
2019-05-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Festenstein HH

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Major Histocompatibility ComplexMajor topic
NeoplasmsMajor topic
Animals
Humans
Leukemia, Experimental
Mice

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
18584190BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.Eur Arch Otorhinolaryngol2009https://conductscience.org/library/papers/18584190PubMed
16610000Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.World J Gastroenterol2006https://conductscience.org/library/papers/16610000PubMed
8956796MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.Br J Cancer1996https://conductscience.org/library/papers/8956796PubMed
8287618In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.Clin Exp Metastasis1994https://conductscience.org/library/papers/8287618PubMed
2972365Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.Cancer Immunol Immunother1988https://conductscience.org/library/papers/2972365PubMed
2839219HLA expression in human hepatocellular carcinoma.Br J Cancer1988https://conductscience.org/library/papers/2839219PubMed
2649129HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.Br J Cancer1989https://conductscience.org/library/papers/2649129PubMed
2462466
Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.
Cancer Immunol Immunother1989https://conductscience.org/library/papers/2462466PubMed
2350918HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.Clin Exp Metastasis1990https://conductscience.org/library/papers/2350918PubMed
2089075Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.Immunol Res1990https://conductscience.org/library/papers/2089075PubMed
2021960Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.Cancer Immunol Immunother1991https://conductscience.org/library/papers/2021960PubMed
1968361Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.Cancer Immunol Immunother1990https://conductscience.org/library/papers/1968361PubMed
1355484Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.J Cancer Res Clin Oncol1992https://conductscience.org/library/papers/1355484PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3315098

GET https://conductscience.org/api/papers/v1/3315098/authors